Hawaii Dept of Health Issues Violations to Four Companies Over Illegal Direct-to-Consumer Lab Testing
State regulators say the companies collected specimens without authorized provider orders, violating Hawaii law.
State regulators say the companies collected specimens without authorized provider orders, violating Hawaii law.
The recipient is recognized for contributions to molecular diagnostics and women's health screening technologies.
Teams complete whole human genome sequencing and analysis in under four hours, demonstrating potential for same-day NICU workflows.
The CLIA-certified facility is now authorized to operate in all 50 states, expanding biomarker testing capabilities nationwide.
The action follows a federal court order that vacated the 2024 rule, reinstating FDA’s prior policy of enforcement discretion for laboratory-developed tests.
Lot-to-lot reagent inconsistencies can have significant effects on patient test results.
The new interim CEO currently serves as senior vice president and chief operating officer at the organization.
Analysis of international surveillance data shows rising resistance to last-line antibiotics, with significant regional variations in treatment outcomes.